24 research outputs found

    New generation of steroidal 4-aminoquinolines as potent antimalarials

    Get PDF
    Sintetisani su novi steroidni 4-amino-7hlorohinolinski derivati i isptana je njihova in vitro antimalarijska aktivnost prema CQ rezistentnim i CQ osetljivim sojevima P. falciparum.Here we present synthesis of new steroidal 4-amino-7-chloroquinolines and dscuss their in vitro antimalarial activities against CQ-resistant and CQ-susceptible P. falciparum stains

    Supplementary material for the article: Videnović, M.; Mojsin, M.; Stevanović, M.; Opsenica, I.; Srdić-Rajić, T.; Šolaja, B. Benzothiazole Carbamates and Amides as Antiproliferative Species. Eur. J. Med. Chem. 2018, 157, 1096–1114. https://doi.org/10.1016/j.ejmech.2018.08.067

    Get PDF
    Supplementary material for: [https://doi.org/10.1016/j.ejmech.2018.08.067]Related to published version: [http://cherry.chem.bg.ac.rs/handle/123456789/2233]Related to accepted version: [http://cherry.chem.bg.ac.rs/handle/123456789/2960

    A Limited Structural Modification Results in a Significantly More Efficacious Diazachrysene-Based Filovirus Inhibitor

    Get PDF
    Ebola (EBOV) and Marburg (MARV) filoviruses are highly infectious pathogens causing deadly hemorrhagic fever in humans and non-human primates. Promising vaccine candidates providing immunity against filoviruses have been reported. However, the sporadic nature and swift progression of filovirus disease underlines the need for the development of small molecule therapeutics providing immediate antiviral effects. Herein we describe a brief structural exploration of two previously reported diazachrysene (DAAC)-based EBOV inhibitors. Specifically, three analogs were prepared to examine how slight substituent modifications would affect inhibitory efficacy and inhibitor-mediated toxicity during not only EBOV, but also MARV cellular infection. Of the three analogs, one was highly efficacious, providing IC50 values of 0.696 mu M +/- 0.13 mu M and 2.76 mu M +/- 0.21 mu M against EBOV and MARV infection, respectively, with little or no associated cellular toxicity. Overall, the structure-activity and structure-toxicity results from this study provide a framework for the future development of DAAC-based filovirus inhibitors that will be both active and non-toxic in vivo
    corecore